Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Classification algorithms with multi-modal data fusion could accurately distinguish neuromyelitis optica from multiple sclerosis.
Cervical and ocular vestibular evoked myogenic potentials in multiple sclerosis participants.
Peptide-functionalized polymeric nanoparticles for active targeting of damaged tissue in animals with experimental autoimmune encephalomyelitis.
Neurology of inherited glycosylation disorders.
Factors affecting dignity of patients with multiple sclerosis.
Intensity of treadmill walking exercise on acute mood symptoms in persons with multiple sclerosis.
Analysis of CH25H in multiple sclerosis and neuromyelitis optica.
Delayed Recovery of Leg Fatigue Symptoms Following a Maximal Exercise Session in People With Multiple Sclerosis.
Decoding movement intent of patient with multiple sclerosis for the powered lower extremity exoskeleton.
Pupillary response to sparse multifocal stimuli in multiple sclerosis patients.
Labeling mesenchymal cells with DMSA-coated gold and iron oxide nanoparticles: assessment of biocompatibility and potential applications.
Pixantrone: a B-cell-depleting immunosuppressant for multiple sclerosis patients with active disease.
Pharmacokinetic considerations in the treatment of multiple sclerosis with interferon-β.
Increased prevalence of lymphoid tissue inducer cells in the cerebrospinal fluid of patients with early multiple sclerosis.
EphB3 receptors function as dependence receptors to mediate oligodendrocyte cell death following contusive spinal cord injury.
Targeting the 18-kDa translocator protein: recent perspectives for neuroprotection.
Elevated Nuclear and Cytoplasmic FTY720-Phosphate in Mouse Embryonic Fibroblasts Suggests the Potential for Multiple Mechanisms in FTY720-Induced Neural Tube Defects.
[Does the Medical Doctor's Pension Fund diagnose multiple sclerosis correct?].
The New England Journal of Medicine publishes pivotal data demonstrating efficacy and safety of oral BG-12 (dimethyl fumarate) in multiple sclerosis.
Impact of transcranial direct current stimulation on fatigue in multiple sclerosis.
Sphingosine-1-phosphate Receptor 1 (S1P1 ) Signaling in T cells: Trafficking and Beyond.
Serum-free spheroid suspension culture maintains mesenchymal stem cell proliferation and differentiation potential.
Minimal clinically important difference for change in comfortable gait speed of adults with pathology: a systematic review.
Myelination, oligodendrocytes, and serious mental illness.
Lipoprotein-associated lysolipids are differentially involved in high-density lipoprotein- and its oxidized form-induced neurite remodeling in PC12 cells.
Pages
« first
‹ previous
…
571
572
573
574
575
576
577
578
579
…
next ›
last »